Associate Clinical Professor, Neurology, UCSF School of Medicine
Neurology
Dr. Bruce A. Cree, MD
|
|
Give Review
Bruce Cree practices Neurology. He went to University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical university. University of California San Francisco School of Medicine is ranked 3 in research and 3 in primary care medicine He received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Bruce A. Cree is a published MD. He published 46 publications, including: 'Mycophenolate Mofetil to Treat Neuromyelitis Optica: Is It Time for a Randomized Trial?' Bruce Cree is registered with Medicare and accepts Medicare payments.
Publications
- Mycophenolate Mofetil to Treat Neuromyelitis Optica: Is It Time for a Randomized Trial?
- Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis.
- A gene pathway analysis highlights the role of cellular adhesion molecules in Multiple sclerosis susceptibility.
- Microcystic inner nuclear layer abnormalities and neuromyelitis Optica.
- Patient preferences for attributes of disease modifying Therapies: Results of a choice based conjoint analysis.
- Interferon beta use and disability prevention in relapsing-remitting Multiple sclerosis.
- Switching Multiple sclerosis patients with breakthrough disease to second-line therapy.
- Identification of new serum autoantibodies in neuromyelitis Optica using protein microarrays.
- Vitamin D in African Americans with Multiple sclerosis.
- Genetic risk and a primary role for cell-mediated immune mechanisms in Multiple sclerosis.
- A whole-genome admixture scan finds a candidate locus for Multiple sclerosis susceptibility.
- Therapeutic considerations for disease progression in Multiple sclerosis: evidence, experience, and future expectations.
- Response to interferon beta-1a treatment in African American Multiple sclerosis patients.
- Acute transverse myelitis: is the "idiopathic" form vanishing?
- Mapping Multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
- Linkage and association with the NOS2A locus on chromosome 17q11 in Multiple sclerosis.
- Mapping of Multiple susceptibility variants within the MHC region for 7 immune-mediated diseases.
- Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA.
- Treatment of neuromyelitis Optica with rituximab: retrospective analysis of 25 patients.
- Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in Multiple sclerosis.
- Genome-wide association analysis of susceptibility and clinical phenotype in Multiple sclerosis.
- Neuromyelitis Optica, psychiatric symptoms and primary polydipsia: a case report.
- Efficacy of Natalizumab Therapy in Patients of African Descent With Relapsing Multiple Sclerosis: Analysis of AFFIRM and SENTINEL Data.
- Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis Optica, in association with elevated serum BAFF levels.
- Refining the association of MHC with Multiple sclerosis in African Americans.
- A major histocompatibility Class I locus contributes to Multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
- Pilot trial of low-dose naltrexone and quality of life in Multiple sclerosis.
- Natalizumab dosage suspension: are we helping or hurting?
- Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis Optica.
- Combining beta interferon and atorvastatin may increase disease activity in Multiple sclerosis.
- Antibody responses against galactocerebroside are potential stage-specific biomarkers in Multiple sclerosis.
- Risk alleles for Multiple sclerosis identified by a genomewide study.
- Emerging monoclonal antibody therapies for Multiple sclerosis.
- Does race matter for Multiple sclerosis?
- Unusual variants of Alexander''s disease.
- Neuromyelitis Optica: diagnosis, pathogenesis, and treatment.
- Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease.
- Asymptomatic spinal cord lesions predict disease progression in radiologically isolated Syndrome.
- Genotype-Phenotype correlations in Multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures.
- Quality of life in multiple sclerosis is associated with lesion burden and Brain volume measures.
- Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis Optica following Optic neuritis.
- Clinical characteristics of African Americans vs Caucasian Americans with Multiple sclerosis.
- Characterizing the mechanisms of progression in Multiple sclerosis: evidence and new hypotheses for future directions.
- An open label study of the effects of rituximab in neuromyelitis Optica.
- Multifactor dimensionality reduction reveals gene-gene interactions associated with Multiple sclerosis susceptibility in African Americans.
Schools
University of California At San Francisco
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Ataxia
- Brain Aneurysm
- Cerebral Artery Thrombosis
- Chronic Inflammatory Demyelinating Polyneuritis
- View All
Doctors Specialties
- Neurology
Accepted Insurances
- Aetna HMO
- Basic HMO
- Choice Plus POS II
- Vitalidad Plus California Con Aetna
- Blue Card PPO
- Blue Cross Blue Shield of California PPO
- Brown & Toland Physicians
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Delta Health System
- First Health (Coventry Health Care) PPO
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Humana
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
New York Presbyterian Hospital -
California Pacific Medical Center -
University of California San Francisco School of Medicine
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1477599454 | |
| NPPES Provider LastName | CREE | |
| NPPES Provider FirstName | BRUCE | |
| NPPES Provider ZIPCode | 941173612 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurology | |
| Total Claim Count | 674.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 1.63 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477599454 |
| Last Name Of The Provider | CREE |
| First Name Of The Provider | BRUCE |
| View All |
Similar Doctors
|
|
Dr. Joey D. English, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sami J. Barmada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James W. Maas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Georges Naasan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil H. Raskin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric C. Wong, MD |
|
|
Dr. Maxime O. Baud, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheila L. Chan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zachary A. Corbin, MD |
|
|
Dr. Robert L. White III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott S. Zamvil, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|